Advertisement
Forex News
TSX Fails To Hold Early Gains, Ends Modestly Lower
After opening on a firm note, the Canadian market slipped into negative territory Friday morning, and stayed weak till the end of the session, and finally ended modestly lower.
RTTNews |
590 days ago
Dollar Turns Mixed Against Major Counterparts
The U.S. dollar is turning in a mixed performance against its major counterparts on Friday, after having climbed higher earlier in the day after hot inflation data raised expectations that the Federal Reserve will keep its monetary policy tight for longer.
RTTNews
|
590 days ago
Swiss Market Ends On Weak Note
The Switzerland stock market ended on a weak note on Friday, tracking weakness in other markets in Europe, as worries about inflation and interest rates weighed on sentiment.
RTTNews
|
590 days ago
European Stocks Close Notably Lower As Growth Worries Rate Concerns Weigh
European stocks closed notably lower on Friday as concerns about interest rates, inflation and geopolitical tensions outweighed stronger than expected earnings updates from some major U.S. lenders.
RTTNews
|
590 days ago
Canadian Dollar Climbs As Oil Prices Soar
The Canadian dollar advanced against its major counterparts in the New York session on Friday, as oil prices surged following the imposition of sanctions by the U.S. on shipping companies that violated the G7's price cap.
RTTNews
|
590 days ago
U.S. Consumer Sentiment Slumps Much More Than Expected In October
Consumer sentiment in the U.S. has deteriorated by much more than anticipated in the month of October, according to preliminary data released by the University of Michigan on Friday. The University of Michigan said its consumer sentiment index slumped to 63.0 in October from 68.1 in September. Economists had expected the index to edge down to 67.4.
RTTNews
|
590 days ago
Swiss Franc Appreciates Against Majors
The Swiss franc firmed against its major counterparts in the New York session on Friday.
RTTNews
|
590 days ago
more news
Genentech Announces New Data From Phase II FENopta Study Of Fenebrutinib For People With RMS
Genentech, Inc., a subsidiary of the Roche Group (RHHBY.PK) announced Friday new data from the Phase II FENopta study showing that investigational, oral fenebrutinib is brain penetrant and reduces brain lesions in people with relapsing multiple sclerosis (RMS). The data has a consistent safety profile to other fenebrutinib trials.
RTTNews
|
590 days ago
U.S. Import Prices Inch Up Much Less Than Expected In September
The Labor Department released a report on Friday showing U.S. import prices inched up by much less than expected in the month of September, although the report also showed a bigger than expected increase in U.S. export prices.
RTTNews
|
590 days ago
Pfizer Says FDA Approves VELSIPITY For Adults With Moderately To Severely Active Ulcerative Colitis
Pfizer Inc. (PFE) announced Friday that the U.S. Food and Drug Administration (FDA) has approved VELSIPITY (etrasimod) for adults with moderately to severely active ulcerative colitis (UC).
RTTNews
|
590 days ago
Sigma Additive Solutions To Acquire NextTrip Holdings In All-stock Deal Valued At About $50 Mln
Quality assurance software firm Sigma Additive Solutions, Inc. (SASI) announced Friday it signed a definitive agreement to acquire travel technology company NextTrip Holdings, Inc.
RTTNews
|
590 days ago
Pound Weakens On Fed, China Worries
The pound dropped against its major counterparts in European deals on Friday, as stronger-than-expected U.S. inflation data strengthened hopes for higher rates and weak China economic data pointed to persistent deflationary pressures in the world's second-largest economy.
RTTNews
|
590 days ago
U.S. Import Prices Show Slight Uptick In September
Following the release of more closely watched inflation data earlier this week, the Labor Department released a separate report on Friday showing U.S. import prices inched up by much less than expected in the month of September.
RTTNews
|
590 days ago
Stay up to date!
Add News to your browser
Add To Chrome
